ReviewFrontiers in endocrinology2026
The exploration and research on the establishment of an early risk assessment system for high-risk diabetic feet.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To develop an early risk assessment system for high-risk diabetic feet. Methods: The system framework was established through literature review and two rounds of Delphi expert consultation. Results: The two rounds of consultation achieved effective response rates of 73.3% and 100.0%, with authority coefficients of 0.802 and 0.933, and Kendall's coefficients of concordance (W) of 0.302 and 0.103 (all P < 0.05). Consensus was reached on an early risk assessment system comprising 6 dimensions (risk factor identification, neurological assessment, vascular evaluation, foot skin and nail examination, self-care ability assessment, and healthcare resource accessibility) and 42 items, enabling structured risk stratification for high-risk diabetic feet. Conclusion: The Delphi-validated system demonstrates good scientific rigor, rationality, practicality, and targetedness. This evidence-based tool can guide nursing training, standardize prevention and control practices, refine teaching programs, and evaluate institutional capabilities for high-risk diabetic foot management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.